EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey

Saleem Ansari, Robert D Garmany Neely iD, Jules Payne, Jaimini Cegla iD

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 2024-05 · 61 (3) · 195-203

DOI: 10.1177/00045632231210682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, online erschienen am 08.11.2023. Verfasst von Saleem Ansari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Lipoprotein(a). Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharmaceuticals UK Limited.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein(a) (Lp(a)) is now established as a causal risk factor for cardiovascular disease (CVD) and accurate laboratory measurement is of pivotal importance in reducing Lp(a) associated risk. The consensus statement by HEART UK in 2019 included recommendations to improve standardisation of clinical laboratory measurement and reporting of Lp(a).

Methods

A 16 question, electronic audit survey was circulated to 190 accredited clinical biochemistry laboratories to assess the adoption of these recommendations in the UK.

Results

Responses were received from 65 of 190 laboratories (34%). Only 5 (8%) did not offer Lp(a) measurement. Of those providing the test, 23% (n = 14) offered an in-house service (IHS), the remaining laboratories (77%; n = 46) used an external referral service (ERS). The majority (10 of 14 or 71%) of IHS laboratories responded with details of their method, stating whether it minimised sensitivity to the effect of Lp(a) isoform size and used calibrators certified for traceability to the WHO/IFCC reference material, however, only a minority ERS laboratories (13 of the 46 or 28%) were able to specify the method used by their referral laboratory. Of the laboratories who specified their reporting units, 6 of 10 IHS and 7 of 23 ERS laboratories reported in nmol/L. Among the 60 laboratories who responded, the HEART UK recommendations appear to have been adopted in full by only 3 IHS laboratories.

Conclusions

Further efforts are needed to standardise the measurement and reporting of Lp(a) so that results and interpretation are comparable across clinical biochemistry laboratories in the UK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)HumansUnited KingdomSurveys and QuestionnairesLaboratories, ClinicalCardiovascular Diseases

Stichwörter der Autor:innen

Cardiovascular riskLipidsLp(a)lipoprotein(a)lipoprotein(a) measurementmeasurement of Lp(a)standardisation

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
  • Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Academic Health Science Network for the North East and North Cumbria, Newcastle Upon Tyne, UK.
  • Heart UK, Maidenhead, UK.

ORCID-Profile: Robert D Garmany Neely, Jaimini Cegla

Förderung

  • Novartis Pharmaceuticals UK Limited

Zitieren

APA

Ansari, S., Garmany Neely, R. D., Payne, J., & Cegla, J. (2024). The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 61(3), 195-203. https://doi.org/10.1177/00045632231210682

Vancouver

Ansari S, Garmany Neely RD, Payne J, Cegla J. The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2024;61(3):195-203. doi:10.1177/00045632231210682

BibTeX
@article{Ansari2024,
  author = {Ansari, Saleem and Garmany Neely, Robert D and Payne, Jules and Cegla, Jaimini},
  title = {The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey},
  journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
  year = {2024},
  volume = {61},
  number = {3},
  pages = {195--203},
  doi = {10.1177/00045632231210682}
}
Kostenlos starten →